Clinical utility gene card for: Hereditary thoracic aortic aneurysm and dissection including next-generation sequencing-based approaches

European Journal of Human Genetics

Volumn 24, Issue 1, 2016, Pages e1-e5

  Arslan Kirchner, Mine ^a   Arbustini, Eloisa ^b   Boileau, Catherine ^c   Charron, Philippe ^d   Child, Anne H ^e   Collod Beroud, Gwenaelle ^f   De Backer, Julie ^g   De Paepe, Anne ^g   Dierking, Anna ^a   Faivre, Laurence ^h   Hoffjan, Sabine ⁱ   Jondeau, Guillaume ^c   Keyser, Britta ^a   Loeys, Bart ^j   Mayer, Karin ^k   Robinson, Peter N ^l   Schmidtke, Jörg ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c BICHAT HOSPITAL   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^f AIX MARSEILLE UNIVERSITY   (France)

^g GHENT UNIVERSITY HOSPITAL   (Belgium)

^h DIJON UNIVERSITY HOSPITAL   (France)

ⁱ RUHR UNIVERSITY BOCHUM   (Germany)

^j UNIVERSITY OF ANTWERP   (Belgium)

^k Center for Human Genetics and Laboratory Medicine Dr Klein   (Germany)

^l CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; BIOLOGICAL MARKER; COLLAGEN; CYTOKINE; MEMBRANE PROTEIN; TRANSCRIPTION FACTOR;

AORTA DISSECTION; ARTICLE; CLINICAL UTILITY GENE CARD; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; GENETIC DATABASE; GENETIC DISORDER; GENETIC RISK; GENETIC SCREENING; HUMAN; INCIDENCE; MUTATIONAL ANALYSIS; NEXT GENERATION SEQUENCING; PRACTICE GUIDELINE; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SANGER SEQUENCING; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; THORACIC AORTA ANEURYSM; VALIDATION PROCESS; ANEURYSM, DISSECTING; AORTIC ANEURYSM, THORACIC; GENE EXPRESSION; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; NOMENCLATURE; PATHOPHYSIOLOGY; QUALITY OF LIFE;

ANEURYSM, DISSECTING; AORTIC ANEURYSM, THORACIC; BIOMARKERS; COLLAGEN; CYTOKINES; GENE EXPRESSION; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MEMBRANE PROTEINS; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; TERMINOLOGY AS TOPIC; TRANSCRIPTION FACTORS;

EID: 84951573589     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2015.225     Document Type: Article

References (20)

1. Loeys BL, Dietz HC, Braverman AC et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010; 47: 476-485
2. Matthijs G, Souche E, Alders M et al. Guidelines for diagnostic next generation sequencing. Eur J Hum Genet 2016; 24: 2-5
3. Lerner-Ellis JP, Aldubayan SH, Hernandez AL et al. The spectrum of FBN1, TGFβR1, TGFβR2 and ACTA2 variants in 594 individuals with suspected Marfan Syndrome, Loeys-Dietz Syndrome or Thoracic Aortic Aneurysms and Dissections (TAAD). Mol Genet Metab 2014; 112: 171-176
4. Landrum MJ, Lee JM, Riley GR et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 2014; 42: D980-D985
5. Milewicz DM, Regalado E. Thoracic aortic aneurysms and aortic dissections. In. Pagon RA, Adam MP, Ardinger HH (eds): Gene Reviews. Seattle, WA, USA: University of Washington, 1993-2014
6. Albornoz G, Coady MA, Roberts M et al. Familial thoracic aortic aneurysms and dissections-incidence, modes of inheritance, and phenotypic patterns. Ann Thorac Surg 2006; 82: 1400-1405
7. Malfait F, De Paepe A. The Ehlers-Danlos syndrome. Adv Exp Med Biol 2014; 802: 129-143
8. Chu LC, Johnson PT, Dietz HC, Fishman EK. CT angiographic evaluation of genetic vascular disease: role in detection, staging, and management of complex vascular pathologic conditions. AJR Am J Roentgenol 2014; 202: 1120-1129
9. Hiratzka LF, Bakris GL, Beckman JA et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/ SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010; 121: e266-e369
10. Erbel R, Aboyans V, Boileau C et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2873-2926
11. Pepin MG, Schwarze U, Rice KM, Liu M, Leistritz D, Byers PH. Survival is affected by mutation type and molecular mechanism in vascular Ehlers-Danlos syndrome (EDS type IV). Genet Med 2014; 16: 881-888
12. Paterick TE, Humphries JA, Ammar KA et al. Aortopathies: etiologies, genetics, differential diagnosis, prognosis and management. Am J Med 2013; 126: 670-678
13. Schoenhoff F, Schmidli J, Czerny M, Carrel TP. Management of aortic aneurysms in patients with connective tissue disease. J Cardiovasc Surg (Torino) 2013; 54 (1 Suppl 1): 125-134
14. Pyeritz RE. Heritable thoracic aortic disorders. Curr Opin Cardiol 2014; 29: 97-102
15. Pyeritz R, Jondeau G, Moran R et al. Loeys-Dietz syndrome is a specific phenotype and not a concomitant of any mutation in a gene involved in TGF-β signaling. Genet Med 2014; 16: 641-642
16. MacCarrick G, Loeys B, Dietz HC 3rd: Response to Pyeritz et al. Genet Med 2014; 16: 642-644
17. Padang R, Bagnall RD, Richmond DR, Bannon PG, Semsarian C. Rare non-synonymous variations in the transcriptional activation domains of GATA5 in bicuspid aortic valve disease. J Mol Cell Cardiol 2012; 53: 277-281
18. Guo DC, Gong L, Regalado ES et al. MAT2A mutations predispose individuals to thoracic aortic aneurysms. Am J Hum Genet 2015; 96: 170-177
19. Barbier M, Gross MS, Aubart M et al. mfap5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections. Am J Hum Genet 2014; 95: 736-743
20. Bertoli-Avella AM, Gillis E, Morisaki H et al. Mutations in a TGFβ ligand, TGFB3, cause syndromic aortic aneurysms and dissections. JACC 2015; 65: 1324-1336